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Increase in serum and salivary 
neutrophil gelatinase-associated 
lipocalin levels with increased 
periodontal inflammation
Objective: This study aimed to determine serum and salivary levels 
of neutrophil gelatinase-associated lipocalin (NGAL) and evaluate NGAL 
correlation with key anti-interleukin 10 (IL-10) and pro-inflammatory (IL-1β) 
cytokines in different severities of periodontal diseases. We also calculated 
the systemic inflammation using the periodontal inflamed surface area (PISA) 
to evaluate its correlation with NGAL in the study groups. Methodology: 
Eighty systemically healthy and non-smoking individuals were separated into 
four groups of 20: clinically healthy (Group 1), gingivitis (Group 2), stage 
I generalized periodontitis (Group 3, Grade A), and stage III generalized 
periodontitis (Group 4, Grade A). Sociodemographic characteristics and 
periodontal parameters were recorded, and PISA was calculated. The serum 
and salivary levels of interleukin (IL)-1β, IL-10, and NGAL were determined 
using the enzyme-linked immunosorbent assay (ELISA). Results: We 
observed a significant increase in serum and salivary NGAL levels from 
healthy to periodontitis groups (p=0.000). Group 2 presented significantly 
higher serum and salivary IL-10 levels and salivary IL-1β levels than Group 
3 (p=0.000). Serum and salivary parameters (IL-1β, IL-10, and NGAL levels) 
were strongly positively correlated to periodontal parameters and PISA values 
(p=0.000). Groups 2 and 3 showed overlapping PISA values. Conclusion: 
The overlapping PISA values found in Groups 2 and 3 suggest that gingivitis 
might progress to a systemic inflammatory burden somewhat comparable 
to stage I periodontitis. This finding is supported by the higher serum and 
salivary cytokines/mediators levels in the gingivitis group than in stage I 
periodontitis group. Serum and salivary NGAL levels increased proportionally 
to disease severity and PISA. NGAL seems to play a role in the pathogenesis 
of periodontal disease, within the limitation of our study.
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Introduction  
Periodontitis is a chronic inflammatory disease 
that shares common mechanistic pathways with 
other systemic inflammatory diseases. Periodontal 
inflammation is regarded as a risk factor for systemic 
inflammation and disease at distant tissues.1 Studies 
have suggested several possible mechanisms by 
which periodontitis might affect distant organs: the 
first is direct migration and colonization of periodontal 
microbial species to distant areas, resulting in an 
inflammatory reaction distant from the invasion point; 
the second is a systemic inflammation resulting from 
metastatic periodontal inflammation or activated 
soluble inflammatory pathways by periodontal 
bacteria.1,2  Nesse, et al.3 (2008) state that the amount 
of inflamed periodontal tissue determines the systemic 
inflammatory burden. The authors developed a meter 
that compares the bleeding pocket epithelium length 
with the periodontal inflamed surface area (PISA).3 
Various studies used the PISA to understand 
the association between systemic diseases and 
periodontitis.4-6 Considering their results, PISA 
may be used as a continuous periodontal variable 
in conjunction with microbiological or biochemical 
variables (cytokine(s)/mediator(s)) in periodontal 
medicine studies, to clarify any potential role in 
the pathogenesis of both periodontal and systemic 
diseases. 
In periodontal disease, host inflammatory cells 
are mobilized on inflammation site and inflammatory 
cytokines are released from fibroblasts, macrophages, 
connective tissue, and junctional epithelial cells.7 One 
of the most important cytokines in the periodontitis-
related immune response and tissue destruction is 
interleukin (IL)-1β, which is produced by macrophages, 
monocytes, lymphocytes, epithelial cells, fibroblasts, 
and osteoblasts,8 has a potent pro-inflammatory 
function,8 and is reported to be present in increased 
levels in the serum, saliva, and gingival crevicular 
fluid (GCF) of periodontitis patients when compared 
to controls.9-11 Studies reported a decrease in serum 
and GCF IL-1β levels after non-surgical periodontal 
treatment.11,12 To control immune-inflammatory 
response and prevent tissue damage, regulatory 
T cells produce cytokines, such as IL-10, to inhibit 
the synthesis of pro-inflammatory cytokines and 
suppress immune-inflammatory-driven alveolar bone 
resorption.13 
Neutrophil gelatinase-associated lipocalin (NGAL) 
belongs to the lipocalin family and has the ability 
to bind iron, fatty acids, prostaglandins, steroids, 
and matrix metalloproteinases.14 A study reported 
NGAL to play an important role in mediating innate 
immunity response to bacterial infections15 by 
sequestrating iron-loaded siderophores. It is also 
a neutrophils chemoattractant, promoting their 
maturation, adhesion and extravasation, and their 
phagocyte capacity, besides activating regulatory T 
cells.14 Due to the elevated circulating NGAL levels 
in the early stages of inflammation, it is considered 
a risk indicator for nephropathy, kidney dysfunction, 
and liver homeostasis.16 IL-1β was found to upregulate 
NGAL in human epithelial cells16 and to possibly 
comprise a determinant for circulating NGAL in 
systemic inflammations.17 A study found IL-10 
overexpression by primary macrophages to enhance 
their pro-resolution activity in complex inflammation-
associated pathologies.18 Likewise, blocking of NGAL 
production in macrophages reduced IL-10 protective 
effects in a kidney ischemia/reperfusion injury model, 
substantiating NGAL-associated pro-proliferative and 
anti-inflammatory properties.18
Although NGAL role in cases of kidney dysfunction 
was widely investigated, studies on its function in the 
pathogenesis of periodontal disease and its association 
with serum and salivary levels and key cytokines in 
periodontitis are still scarce. The literature reported 
NGAL presence in GCF and saliva18,19 and suggested 
the neutrophils extravasated is main source of this 
protein in these biological fluids and in gingiva.19 
NGAL has been reported to be a salivary biomarker 
in patient monitoring and disease activity control,20 
and urinary NGAL has been indicated for clinicians to 
screen periodontitis.21 Considering the lack of studies 
in the existing literature on periodontitis regarding 
the role of NGAL and its association with cytokines/
mediators in the pathogenesis of periodontal diseases, 
it is logical to evaluate NGAL association with IL-1β and 
IL-10 and determining its function in the pathogenesis 
of periodontitis.
This study aimed to evaluate serum and salivary 
NGAL levels in different types of periodontal diseases 
and different levels of disease severity. We also sought 
to investigate whether NGAL levels in local (saliva) 
and systemic environments (serum) proportionally 
increase with increased severity, bleeding, and size of 
the ulcerated periodontal inflamed surface area (PISA).
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Methodology
This study was approved by the Clinical Research 
Ethics Committee of the Faculty of Medicine of the 
Süleyman Demirel University (SDU) (16.08.2017, 
decision No. 121) and conducted in accordance with the 
Declaration of Helsinki from 1975 as revised in 2013. 
The study population consisted of 80 participants who 
applied to the SDU, Faculty of Dentistry, Department 
of Periodontology, between September 2017 and 
November 2018. All participants were required to 
sign a consent form before participating in the study.
Exclusion criteria
Individuals were excluded from the study if they: 
were previously diagnosed with a systemic disease, 
older than 65, using any medication affecting values 
of periodontal parameters, smokers, had received 
periodontal or antibiotic treatment within the six 
months prior to the study, presented necrotizing 
ulcerative gingivitis, were receiving orthodontic 
treatment, had alcohol or substance dependence, had 
less than 20 teeth, or refused to sign the consent form.
Patient groups 
Patients were assessed for evidence of periodontal 
disease and classified according to the New Classification 
Scheme for Periodontal and Peri-Implant Diseases and 
Conditions proposed in the 2017 World Workshop22 
and divided into four groups: periodontally healthy 
(Group 1, n=20), gingivitis (Group 2, n=20), stage I 
generalized periodontitis (Group 3, n=20), and stage 
III generalized periodontitis (Group 4, n=20). All 
patients with periodontitis (Group 3 and Group 4) were 
Grade A (no attachment loss over 5 years, % bone 
loss/age: 0.25-1.0 mm, heavy biofilm deposits with 
low levels of destruction, non-smoker, normoglycemic/
no diagnosis of diabetes).22  
Periodontally healthy group is characterized by 
no or minimal levels of clinical inflammation in a 
periodontium with normal support (clinical periodontal 
health: no/minimal bleeding on probing [BOP <10%], 
normal gingival sulcus depth and bone heights, 
controlled modifying and predisposing factors).23 
Gingivitis group is  characterized by no probing 
attachment loss (AL), and radiographic bone loss and 
BOP score ≥ 10% and ≤ 30% (gingivitis in an intact 
periodontium).23 Stage I periodontitis is characterized 
by 1 to 2 mm AL at greatest loss site, radiographic bone 
loss in coronal third (<15%), and no tooth loss due to 
periodontitis.22 Stage III periodontitis is characterized 
by ≥ 5 mm AL at greatest loss site, radiographic bone 
loss extending to mid-third or apical third of root, 
and ≤ 4 teeth loss due to periodontitis.22 Periodontitis 
extent was determined as generalized (≤ 30% of teeth 
involved) according to the criteria proposed by the 
1999 International Workshop for the Classification of 
Periodontal Diseases and Conditions and by the 2017 
World Workshop on the Classification of Periodontal 
and Peri-Implant Diseases and Conditions.22,23 
Patients were also evaluated for healthy, suffering 
from gingivitis, and suffering from periodontitis – 
criteria proposed by the 1999 International Workshop 
for the Classification of Periodontal Diseases and 
Conditions.24 Classification was further sub-divided by 
severity (mild, moderate, or severe), as jointly defined 
by the Centers for Disease Control and Prevention 
(CDC) and the American Academy of Periodontology 
(AAP).25 Considering CDC-AAP classification,25 groups 
may be summarized into: periodontally healthy 
(Group 1), gingivitis (Group 2), mild periodontitis 
(Group 3, ≥ 2 interproximal sites with AL ≥ 3 mm, 
and ≥ 2 interproximal sites with probing depth (PD) 
≥ 4 mm [on different teeth] or one site with PD ≥ 5 
mm), moderate and severe periodontitis (Group 4, 
moderate: ≥ 2 interproximal sites with AL ≥ 4 mm [on 
different teeth], or ≥ 2 interproximal sites with PD ≥5 
mm [on different teeth]; and severe: ≥ 2 interproximal 
sites with AL ≥ 6 mm [on different teeth] and ≥ 1 
interproximal site with PD ≥ 5 mm). 
Sample size determination
Sample size was determined according to the 
metrics established by Leira, et al.26 (2018), at 
0.05 significance level and 80% statistical power. 
Considering PISA value between periodontally healthy 
patients and those with severe periodontitis, we found 
a minimum of 20 subjects per group. 
Sociodemographic and dental characteristics
Sociodemographic (age, gender, education level, 
monthly income, height, and weight) and dental 
characteristics (toothbrushing frequency, frequency 
of dental visits, use of interdental hygiene equipment, 
such dental floss, waterpick, toothpick) were recorded.
Periodontal evaluation
A single qualified investigator (A. Tan) performed 
periodontal examination (intraclass correlation 
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coefficients [ICC] for periodontal probing depth 
[PPD] was 0.997 and for AL 0.995). Gingival index 
(GI)27 and plaque index (PI)28 were recorded for 
four sites on each tooth (mesiobuccal, midbuccal, 
distobuccal, and mesiolingual/palatal). BOP, AL and 
PPD scores were obtained for six sites (mesiobuccal, 
mid-buccal, distobuccal, mesiolingual, mid-lingual, 
and distolingual) using a Williams periodontal probe 
(Hu-Friedy Manufacturing Corp., Chicago, IL, USA.). 
All measurements were rounded to the nearest 0.5 
mm, except for PPD and AL, which were rounded to 
the nearest whole mm. BOP percentage was calculated 
as the number of teeth exhibiting any bleeding.29 
BOP scores obtained from the six sites were used 
for calculating periodontal inflamed surface area 
(PISA) and periodontal epithelial surface area (PESA) 
scores.3 For each tooth, the PESA was calculated using 
the clinical AL and recession area and the PISA was 
obtained from PESA multiplied by the number of sites 
with BOP. The sum of individual PISA values results in 
the full-mouth PISA value, in square mm3.  
Saliva samples
Unstimulated whole saliva was collected from all 
patients using a passive drool into sterile plastic tubes 
between 9 and 10 am, for 5 minutes, according to the 
method established by Navazesh and Kumar30 (2008). 
Participants were requested to refrain from eating, 
drinking, chewing gum, or breath mints, as well as 
performing oral hygiene procedures for at least one 
hour prior to saliva collection. After collection, samples 
were placed on ice and aliquoted before being storaged 
at -80°C. 
Serum samples
Fasting blood samples from the antecubital vein 
were collected using blood collection tubes with 
anticoagulant (EDTA, Greiner AG, Kremsmünster, 
Austria) and centrifuged at 3000 × g for 10 minutes. 
Before analysis, serum samples were portioned and 
stored at −80°C. 
After all the periodontal measurements were 
recorded and salivary and serum samples were taken, 
periodontal therapy was administered according to the 
individual needs.
Biochemical analysis
Serum and saliva IL-1β, IL-10, and NGAL levels 
were determined using human-specific enzyme-
linked immunosorbent assay (ELISA) kits (Shangai 
YLbiont Biotech Co., Shangai, China), which is based 
on the biotin double-antibody sandwich technology 
to quantify specific IL-1β, IL-10, and NGAL antigens. 
Serum samples were diluted 1:10 and saliva 1:50 
before analysis, assuming the specific standard curve 
with eight different concentrations for each parameter. 
Kits’ sensitivity values were 10.07 pg/L (IL-1β), 12.3 
pg/L (IL-10), and 5.01x106 pg/L (NGAL). 
Statistical analysis
Data were analyzed to verify whether they 
fulfilled parametric tests preconditions (Box’ M test 
for homogeneity of variance-covariance matrices 
and Kolmogorov-Smirnov test for normal distribution 
prerequisites). If preconditions were fulfilled, data 
were analyzed using one-way analysis of variance 
(ANOVA); if not, Kruskal-Wallis test was applied. In 
the parametric case, Tukey’s multiple comparison 
test was used after ANOVA to determine statistical 
differences among groups. In the non-parametric 
case, the Bonferroni-Dunn test was applied after the 
Kruskal-Wallis test to identify multiple comparisons. 
Categorical demographic data (gender, education 
level, monthly income, dental visit frequency, brushing 
frequency, and interdental cleaning frequency) 
was analyzed with the chi-square test. Spearman’s 
correlation was used to determine any correlations 
between parameters. A p-value less than or equal 
to 0.05 was considered statistically significant. All 
statistical analyses were performed with commercial 
statistical software (IBM SPSS Statistics for Windows, 
version 23, IBM Corp., Armonk, NY, USA).
Results
Eighty patients (35 females and 45 male) aged 
between 25 and 63 years participated in the study. 
Table 1 shows the study population sociodemographic 
parameters and characteristics. We found no 
statistically significant differences between Groups 
3 and 4 (p=0.966) and Groups 1 and 2 (p=0.142) 
regarding age. Mean age was significantly lower in 
Group 1 than in Groups 3 and 4 (Groups 1 and 3, 
p=0.001, Groups 1 and 4, p=0.000), but Group 2 
showed no significant difference in relation to other 
groups (Group 1, p=0.142; Group 3, p=0.330; Group 
4, p=0.142). We found a strong negative correlation 
between periodontitis severity and education level 
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(p=0.000). Monthly income showed no significant 
difference among groups (p=0.880). As for body mass 
index (BMI), we observed both statistically significant 
(Groups 1 and 4, p=0.031) and non-significant 
differences (Group 1 and 2, p=0.254; Group 1 and 3, 
p=0.076; Group 2 and 3, p=0.934; Group 2 and 4, 
p=0.774; Group 3 and 4, p=0.983).
Table 2 shows PISA and PESA values for the four 
groups. Periodontal inflamed surface area (PISA) 
and periodontal ephithelial surface area (PESA) 
values increased with disease severity and were 
significantly different among groups (p=0.000). 
Group 4 presented the highest plaque index (PI) and 
gingival index (GI) values and Group 1 the lowest. We 
found no statistically significant differences in PI and 
GI values between Groups 2 and 3 (p>0.05) and in 
periodontal parameters, (periodontal probing depth 
-PPD, attachment loss – AL, PISA, and PESA) among 
all groups (p<0.05). 
Figure 1 shows salivary (Figure 1a) and serum 
(Figure 1b) IL-1β, IL-10 and NGAL levels and 
comparisons among groups. Salivary IL-1β levels were 
significantly higher in Group 2 than in Groups 3 and 1 
(p=0.045, and p=0.000), but significantly lower than 
Group 4 (p=0.000). However, salivary IL-10 levels 
showed no statistically significant differences between 
Groups 2 and 3 (p=0.923), but were significantly lower 
in Group 1 when compared to Group 4 (p=0.000). 
Salivary NGAL levels increased significantly alongside 
disease progression from periodontally health to stage 
III periodontitis; all groups were significantly different 
from each other (p=0.000).
Serum IL-1β levels progressively increased 
from group to group, from periodontal health to 
periodontitis, and were significantly different among 
groups (p=0.000). Although serum IL-10 levels 
increased in the transition from periodontally health to 
periodontal compromised groups (p=0.000), Groups 2 
and 3 presented no significant differences (p=0.450). 
Groups 2 and 3 had significantly lower IL-10 levels than 
Group 4 and higher levels than Group 1 (p=0.000). 
Serum NGAL levels increased significantly alongside 
disease progression, and all groups were significantly 
different from each other (p=0.000).
Groups
Parameters    Categorizations Group 1 Group 2 Group 3 Group 4
Age
Min.-Max. 25-50 25-54 25-60 25-63
Mean±SD 29.00±5.56§, ‖ 35.05±8.52 39.80±10.61† 41.10±9.77†
Gender (n) Female 7    10    14    9    
Education level (n)
Elementary (8 years) 1 3 8 8
Secondary (8-12 years) 0 5 6 7
Higher (12 years<) 19 12 6 5
Monthly income (n)
0-1500 TL 2 4 2 0
1500-3000 TL 6 7 10 11
>3000 TL 12 9 8 9
BMI (kg/m2)
Min.-Max. 18.4-27.5 18.8-28.7 18.8-32.9 19.7-34.9
Mean±SD 22.64±2.66‖ 24.59±2.98 25.21± 3.51 25.59±3.93†
Dental visit frequency (n)
In case of need 0 1 17 20
1/ 2-3 years 0 4 1 0
1 or 2 times/year 20 15 2 0
Brushing frequency (n)
Rarely 0 1 1 1
2-3 times/week 0 4 6 10
1-2 times/day 20 15 13 8
Interdental cleaning (n)
Never 3 18 18 20
Rarely 4 1 2 0
2-3 times/week 7 1 0 0
1-2 time/day 6 0 0 0
NOTES: 1 USA Dollar currency rate was between 3.66 and 5.24 TL and the minimum wage was 1500 TL during the period within 
which this study was conducted.  BMI: body mass index. †: significantly different than Group 1, ‡: significantly different than Group 2, §: 
significantly different than Group 3, ‖: significantly different than Group 4 (p<0.05, Chi-Square test, ANOVA, and Tukey's Test.).
Table 1-  Sociodemographic parameters and characteristics of the study groups
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All clinical periodontal parameters were significantly 
and strongly correlated with other clinical periodontal, 
serum, and salivary parameters. All serum and salivary 
parameters were significantly and strongly correlated 
with all other serum and salivary parameters (p=0.000, 
data not shown, added as supplementary material).
Discussion 
This cross-sectional study aimed to investigate 
whether increased periodontitis severity, bleeding, 
and ulcerated periodontal inflamed surface area (PISA) 
increase NGAL levels in local (saliva) and systemic 
environments (serum). We also investigated whether 
gingivitis causes a systemic inflammatory burden as 
high as periodontitis. Our results verified and answered 
these study questions.  
Sociodemographic parameters and characteristics 
regarding education level, monthly income, dental 
visit frequency, and oral hygiene habits were not 
significantly different among groups. The significant 
age difference between groups (lower age in Group 
1) could be deemed as a limitation. However, to 
the best of our knowledge, there are no studies in 
the literature reporting that age could affect serum 
and salivary IL-1β, IL-10, and NGAL levels. In turn, 
the available knowledge on the effects of ageing in 
immunity31 led us to understand that age differences 
between groups cause no impact on the investigated 
parameters, considering the lack of individuals older 
than 65 years in our study population. 
We found significantly higher body mass index 
(BMI) values in stage III periodontitis group than 
in healthy group, although similar to other groups. 
Our study groups presented mean BMI below obesity 
Groups
Parameters Group 1 Group 2 Group 3 Group 4
NT
Mean Rank 51.45§, ‖ 44.03§, ‖ 28.9 3†, ‡ 37.60†, ‡
Min.-Max. 24-28 23-28 20-28 24-28
Mean±SD 27.70±0.98 27.20±1.44 25.35±2.89 26.90±1.41
PI
Mean Rank 10.50‡, §, ‖ 40.45†, ‖ 47.38†, ‖ 63.68†, ‡, §
Min.-Max. 0.25-0.88 1.01-2.54 1.60-2.13 1.81-2.91
Mean±SD 0.38±0.16 1.80±0.36 1.93±0.15 2.20±0.26
GI
Mean Rank 10.50‡, §, ‖ 39.63†, ‖ 45.78†, ‖ 66.10†, ‡, §,
Min.-Max. 0.13-0.73 1.30-2.25 1.66-2.04 1.86-2.70
Mean±SD 0.33±0.13 1.77±0.25 1.90±0.11 2.15±0.20
BOP (%)
Mean Rank 10.50‡, §, ‖ 45.98†, §, ‖ 52.03†, ‡ 53.50†, ‡
Min.-Max. 0-8 85-100 93-100 100-100
Mean±SD 6±3 97±5 99±2 100±0
PPD (mm)
Mean Rank 10.55‡, §, ‖ 31.20†, §, ‖ 50.90†, ‡, ‖ 69.35†, ‡, §
Min.-Max. 1.08-1.72 1.67-2.48 2.04-3.05 2.75-6.16
Mean±SD 1.34±0.17 2.09±0.20 2.72±0.26 3.80±0.89
AL (mm)
Mean Rank 10.55§, ‖ 30.5 5 §, ‖ 51.50†, ‡,  ‖ 69.40†, ‡, §
Min.-Max. 0 0 2.43-3.75 3.11-7.85
Mean±SD 0 0 3.09±0.41 4.61±1.35
PISA (mm2)
Mean Rank 10.50‡, §, ‖ 31.90†, §, ‖ 49.55†, ‡, ‖ 70.05†, ‡, §
Min.-Max. 0-34.51 649.78-1191.61 962.57-1467.79 1250.77-3353.57
Mean±SD 14.89±9.30 893.38±158.04 1187.67±132.52 2152.41±649.09
PESA (mm2)
Mean Rank 10.7‡, §, ‖ 31.65†, §, ‖ 49.9†, ‡, ‖ 69.75†, ‡, §
Min.-Max. 585.46-839.65 832.99-1297.89 986.32-1694.88 1342.35-3934.64
Mean±SD 754.39±30.89 1057.18±117.66 1352.84±169.96 2313.39±721.11
†: significantly different than Group 1, ‡: significantly different than Group 2, §: significantly different than
Group 3, ‖: significantly different than Group 4 (p<0.05, ANOVA,  Kruskal-Wallis test, Bonferroni-Dunn test).
AL: clinical attachment loss, BOP: bleeding on probing, GI: gingival index, PI: plaque index, PISA: periodontal ınflamed surface area, 
PESA: periodontal epithelial surface area, PPD: periodontal pocket depth
Table 2- Dental and periodontal characteristics and periodontal epithelial and periodontal inflamed surface area (PISA and PESA) values 
of the study population
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limit, suggesting that obesity level does not affect 
our study population periodontal status and disease 
severity. BMI values were not significantly correlated 
with salivary and serum parameters (data not 
shown). Meta-analysis and systematic reviews state 
that overweight, obesity, weight gain, and increased 
waist circumference may represent risk factors for 
the development of periodontitis or worsening of 
periodontal condition.32,33 Corroborating our results, 
Syrjäläinen, et al.34 (2019) reported that salivary 
cytokine concentrations were affected by periodontal 
severity rather than by obesity. Satpathy, et al.35 
(2015) suggested that serum IL-1β levels were higher 
in periodontitis patients with abdominal obesity. Our 
study did not employ waist circumference and waist 
to hip ratio, only BMI values; yet, patients with BMI 
higher than 29 kg/m2 were not considered cases of 
abdominal obesity. Arboleda, et al.36 (2019) conducted 
a review to summarize epidemiological studies, and 
suggested that the association between obesity 
and periodontitis may be overestimated due to the 
different definitions of periodontitis cases adopted by 
their evaluated studies. In our study, BMI difference 
between healthy and moderate-severe periodontitis 
group could be considered a limitation, and our results 
should be evaluated with caution. 
Among the studied clinical periodontal parameters, 
the periodontally healthy group presented the lowest 
plaque index (PI) and gingival index (GI) values, while 
stage III periodontitis patients (Group 4) presented the 
highest values. Oral hygiene habits influenced disease 
presence and/or severity in our study population.37 
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Figure 1- A: Salivary IL-1 β, IL-10, and NGAL levels, B: Serum IL-1 β, IL-10, and NGAL levels and comparisons between groups. †: 
significantly different than Group 1, ‡: significantly different than Group 2, §: significantly different than Group 3, ‖: significantly different 
than Group 4 (p<0.05,  ANOVA and Tukey’s Test).
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Groups 3 and 4 showed the highest bleeding on 
probing (BOP) values. Plaque and edema presence 
was similar between the two groups (gingivitis 
and stage I periodontitis). Yet, tissue damage was 
more evident in the stage I periodontitis (Group 3) 
than in gingivitis patients (Group 2), indicating that 
periodontal disease progression is related to immune 
response to biofilm.38 Bleeding, which indicates 
ulceration of pocket epithelium, is an important finding 
that links periodontal diseases to systemic diseases. 
PISA,3 a continuous periodontal variable in periodontal 
medicine studies used to calculate surface area 
bleeding and obtained by BOP, periodontal probing 
depth (PPD) and attachment loss (AL) values, was 
significantly different among groups. Groups with 
gingivitis (Group 2) and stage I periodontitis (Group 
3) presented overlapping values. 
Despite the belief that PISA may help classify 
the degree of periodontal disease, PISA threshold 
values are yet to be determined. In our study, PISA 
values were consistent with the current classification 
for periodontal diseases22 (as well as with the former 
CDC-AAP classification),24,25 and increased with 
periodontal disease presence and increased severity. 
When compared to the other studies,4-6 the higher 
PISA values reported in our study may be explained 
by the periodontitis generalized involvement of our 
groups. Another important finding suggests that 
gingivitis can cause as much systemic inflammatory 
burden as stage I periodontitis: the overlap in PISA 
values and the positive strong correlations between 
PISA and pro- and anti-inflammatory biomarker 
levels in gingivitis and stage I periodontitis groups. 
To the best of our knowledge, this is the first study to 
investigate serum and salivary NGAL levels considering 
different periodontal diseases and severity. We 
found all periodontal parameters and PISA values to 
proportionally increase with increased disease severity 
and NGAL levels. 
Periodontal disease progresses if the balance 
between pro- and anti-inflammatory cytokines in 
periodontal tissues is disturbed in favor of pro-
inflammatory cytokines.7  We investigated IL-1β, a key 
pro-inflammatory cytokine in tissue damage. Salminen, 
et al.39 (2014) showed that salivary IL-1β levels were 
critical for periodontal disease progression. In our 
study, serum IL-1β levels progressively increased from 
healthy (Group 1) to stage III periodontitis (Group 
4) and salivary IL-1β levels were higher in gingivitis 
group than in stage I periodontitis group. This finding 
confirms that IL-1β is an important cytokine in the 
transition from gingivitis to periodontitis, corroborating 
results reported in the literature. 
We also investigated another important anti-
inflammatory cytokine, the IL-10. Information on IL-10 
levels reported in the literature are still conflicting: 
whereas Andrukhov, et al.40 (2011) reported that 
serum IL-10, TNF-a, and IFN-a levels were higher 
in individuals with periodontitis than in healthy 
individuals, Teles, et al.41 (2009) reported that saliva 
IL-10 levels were lower in periodontitis patients than in 
healthy individuals and salivary IL-1β levels were higher 
in periodontitis patients than in healthy individuals. In 
our study, stage III periodontitis (Group 4) presented 
the highest values of both serum and salivary IL-10 
levels, corroborating Teles, et al.41 (2009), while the 
periodontally healthy group (Group 1) presented the 
lowest values. We found no statistically significant 
difference between gingivitis and stage I periodontitis, 
in line with our study hypothesis. This may suggest 
that periodontal disease may progress more rapid in 
individuals with low anti-inflammatory capacity, and 
that the immune system of individuals with gingivitis 
is as active those with in stage I periodontitis. 
A study reported circulating NGAL to be regulated 
by IL-1β in systemic inflammatory conditions.16 IL-1β 
was reported to be the major inductive cytokine of 
NGAL by NF-kB activation in an experimental acute-
on-chronic liver failure model.16 The positive strong 
correlations between serum and salivary NGAL and 
serum and salivary IL-1β found in our study support 
these studies. Increased serum and salivary IL-1β 
levels induced the increase in serum and salivary NGAL 
levels from healthy to severe periodontal disease.  
By investigating the association between NGAL 
and IL-10, a study found that the inhibition of NGAL 
decreased IL-10 expression by macrophages and 
the pro-proliferative and anti-inflammatory NGAL 
role in a renal ischemia-reperfusion model.18 The 
role of NGAL in periodontal disease pathogenesis, as 
regulated by IL-1β and IL-10, could be conjectured 
within the limitations of this study, as supported by 
the increased serum levels progressing from health to 
disease. In our study, serum and salivary NGAL levels 
were statistically different among the study groups by 
progressively increasing with increased severity and 
PISA. Serum and salivary NGAL showed a significant 
and strong positive correlation with periodontal 
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clinical parameters and PISA, suggesting that NGAL 
plays an increasing role in cases of periodontitis with 
exacerbated inflammation and increased ulcerated 
bleeding surface area. 
Our study poses several limitations. First, its cross-
sectional design does not enable an analysis of NGAL in 
the pathogenesis of periodontal disease, which requires 
future randomized case-control studies investigating 
the cut-off values of serum and salivary NGAL levels 
in periodontally healthy and compromised patients, 
and employing interventional approaches (comparing 
NGAL levels before and after non-surgical periodontal 
therapy). Secondly, the presence of obese patients 
in periodontally compromised groups (although not 
significant among groups) might have affected salivary 
and serum NGAL levels. As fat distribution (determined 
by waist/hip ratio or waist circumference) was reported 
to be associated with periodontitis rather than higher 
BMI,42 the lack of such measurements could pose a 
limitation to observe clear associations between the 
investigated parameters. 
Conclusion
Despite the limitations of our study, NGAL seems to 
play a role in the pathogenesis of periodontal disease, 
as its increasing level is associated with the presence 
and severity of the disease. This finding is supported 
by the significant and strong correlations between 
NGAL and clinical parameters, as well as serum and 
salivary IL-1β and IL-10 levels.
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